Paper804350
Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
Goldsmith MA and 2 others. Cancer Res, 1975. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Papers, record 804350. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/804350
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Drug Evaluation, Preclinical | Major topic |
| Toxicology | Major topic |
| Animals | |
| Dogs | |
| Haplorhini | |
| Lethal Dose 50 | |
| Leukemia L1210 | |
| Mice | |
| Retrospective Studies |
Source PubMed
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42906064 | Measuring AI Progress in Drug Discovery: A Reproducible Leaderboard for the Tox21 Challenge. | J Chem Inf Model | 2026 | https://conductscience.org/library/papers/42906064 | PubMed |
| 32468223 | Iron Overload Resulting from the Chronic Oral Administration of Ferric Citrate Impairs Intestinal Immune and Barrier in Mice. | Biol Trace Elem Res | 2021 | https://conductscience.org/library/papers/32468223 | PubMed |
| 31699955 | Iron overload resulting from the chronic oral administration of ferric citrate induces parkinsonism phenotypes in middle-aged mice. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31699955 | PubMed |
| 29067202 | Tolerability of a rapid-escalation vinblastine-prednisolone protocol in dogs with mast cell tumours. | Vet Med Sci | 2016 | https://conductscience.org/library/papers/29067202 | PubMed |
| 28911474 | Use of a failure probability constraint to suggest an initial dose in a phase I cancer clinical trial. | J Food Drug Anal | 2014 | https://conductscience.org/library/papers/28911474 | PubMed |
| 26763733 | Folate-targeted pH-responsive calcium zoledronate nanoscale metal-organic frameworks: Turning a bone antiresorptive agent into an anticancer therapeutic. | Biomaterials | 2016 | https://conductscience.org/library/papers/26763733 | PubMed |
| 26066655 | Targeted Cancer Therapy with a Novel Anti-CD37 Beta-Particle Emitting Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma. | PLoS One | 2015 | https://conductscience.org/library/papers/26066655 | PubMed |
| 26056373 | Species differences in tumour responses to cancer chemotherapy. | Philos Trans R Soc Lond B Biol Sci | 2015 | https://conductscience.org/library/papers/26056373 | PubMed |
| 23609628 | Intravenous and subcutaneous toxicity and absorption kinetics in mice and dogs of the antileishmanial triterpene saponin PX-6518. | Molecules | 2013 | https://conductscience.org/library/papers/23609628 | PubMed |
| 22963674 | Animal models and conserved processes. | Theor Biol Med Model | 2012 | https://conductscience.org/library/papers/22963674 | PubMed |
| 22957928 | The Interactions between L-tyrosine based nanoparticles decorated with folic acid and cervical cancer cells under physiological flow. | Mol Pharm | 2012 | https://conductscience.org/library/papers/22957928 | PubMed |
| 20877440 | The war on cancer: have we won the battle but lost the war? | Oncotarget | 2010 | https://conductscience.org/library/papers/20877440 | PubMed |
| 19384685 | Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experience. | J Biopharm Stat | 2009 | https://conductscience.org/library/papers/19384685 | PubMed |
| 19174777 | Pharmacogenomic progress in individualized dosing of key drugs for cancer patients. | Nat Clin Pract Oncol | 2009 | https://conductscience.org/library/papers/19174777 | PubMed |
| 11145233 | A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology. | Pharm Res | 2000 | https://conductscience.org/library/papers/11145233 | PubMed |
| 10555743 | Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10555743 | PubMed |
| 9068927 | The clinical pharmacokinetics of cladribine. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9068927 | PubMed |
| 8527281 | Stereospecific pharmacokinetics of rac-5-methyltetrahydrofolic acid in patients with advanced colorectal cancer. | Br J Clin Pharmacol | 1995 | https://conductscience.org/library/papers/8527281 | PubMed |
| 7695336 | Pharmacokinetics of michellamine B, a naphthylisoquinoline alkaloid with in vitro activity against human immunodeficiency virus types 1 and 2, in the mouse and dog. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7695336 | PubMed |
| 7389061 | Evaluation of antitumor drug side effects in small animals. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7389061 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/804350
GET https://conductscience.org/api/papers/v1/804350/cited_by?page=2